Name: Health Canada approves Ozempic to reduce risk of kidney decline among type 2 diabetes patients
Uploaded: 2025-08-19T23:29:42Z
Duration: 1 min 56 s
Description: Health Canada has now approved Ozempic to reduce the risk of kidney decline among patients with type 2 diabetes.

Toronto Watch

Health Canada approves Ozempic to reduce risk of kidney decline among type 2 diabetes patients

Health Canada has now approved Ozempic to reduce the risk of kidney decline among patients with type 2 diabetes. CTV's health reporter Pauline Chan reports.

August 19, 2025 at 6:44PM EDT